Dr. Stuart Gordon, MD

• Gastroenterology

• Transplant Hepatology

• Hepatology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Wayne State University School Of Medicine

  Medical School

• University Of Miami Miller School Of Medicine

  Fellowship Hospital, 1985

• Beaumont Hospital Royal Oak

  Residency Hospital, 1983

• Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States The quality-adjusted cost of care, 2016-10-14

• Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes, 2019-01-16

• Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States, 2018-01-29

• Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy, 2012-10-08

• The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health Records, 2017-07-05

• Genome-Wide Analysis of DNA Methylation, Copy Number Variation, and Gene Expression in Monozygotic Twins Discordant for Primary Biliary Cirrhosis, 2014-03-28

• Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load, 2013-05-03

• Differences in Hepatic Phenotype Between Hemochromatosis Patients withHFEC282Y Homozygosity and OtherHFEGenotypes, 2009-01-21

• Predictors of consent to pharmacogenomics testing in the IDEAL study, 2014-03-06

• Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials, 2015-03-19

• Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis, 2011-01-01

• Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016), 2022-03-01

• Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure, 2019-07-04

• A Case of Hemophagocytic Lymphohistiocytosis Secondary to Disseminated Histoplasmosis, 2020-08-20

• Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET, 2014-09-10

• Corrigendum: Genome-Wide Analysis of DNA Methylation, Copy Number Variation, and Gene Expression in Monozygotic Twins Discordant for Primary Biliary Cirrhosis, 2014-08-14

• Mental and physical health status among chronic hepatitis B patients, 2020-01-14

• Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C, 2019-01-24

• Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study, 2023-04-06